Education
About Us
Working with TipRanks
Follow Us
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
| Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -74.59M | $ -36.91M | $ -8.70M |
| EBITDA | $ -74.59M | $ -36.91M | $ -51.61M |
| Net Income | $ -69.33M | $ -36.91M | $ -51.61M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 150.39M | $ 163.37M | $ 37.28M |
| Total Assets | $ 163.10M | $ 182.83M | $ 43.04M |
| Total Debt | $ 317.00K | $ 139.00K | $ 0.00 |
| Net Debt | $ -150.07M | $ -163.23M | $ -37.28M |
| Total Liabilities | $ 11.80M | $ 8.37M | $ 1.82M |
| Stockholders' Equity | $ 151.30M | $ 174.46M | $ 41.22M |
| Cash Flow | |||
| Free Cash Flow | $ -55.84M | $ -43.63M | $ -12.59M |
| Operating Cash Flow | $ -55.84M | $ -43.63M | $ -12.59M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -40.00M |
| Financing Cash Flow | $ 42.86M | $ 169.72M | $ 89.87M |